Fibrin degradation product

When the clot and fibrin net dissolve, fragments of protein are released into the body.

If your body is unable to dissolve a clot, you may have abnormal levels of FDPs.

Fibrin and fibrinogen degradation product (FDP) testing is commonly used to diagnose disseminated intravascular coagulation.

[2] A tumor marker known as AMDL-ELISA DR-70 (FDP), and now as Onko-Sure, was approved by the US FDA on July 1, 2008 for in vitro diagnostic only and serial testing for monitoring colorectal cancer with more effective by 50 percent than carcinoembryonic antigen (CEA) when CEA values is low.

The Onko-Sure blood test can detect also tumors/cancers: of lung, breast, stomach, liver, colon; rectal, ovarian, esophageal, cervical, trophoblastic, thyroid, malignant lymphoma, and pancreatic.